Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADP-Glo Kinase Assay from US Patent US20240101538: "PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER"
Assay data:3 Active, 3 Activity ≤ 1 µM, 10 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
assay on hold
Summary
DYRK1A SGC Tm panel (DSF)
Assay data:1 Tested
SummaryRelated BioAssays by Target
STK6 SGC Tm panel (DSF)
MAPK1 SGC Tm panel (DSF)
MAPK1 Invitrogen Lab (UK) kinase screen (BI)
Inhibition of Aurora A (unknown origin) at 10 uM by biochemical hotspot kinase assay
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of ERK1 (unknown origin) at 10 uM by biochemical hotspot kinase assay
Inhibition of ERK2 (unknown origin) at 10 uM by biochemical hotspot kinase assay relative to control
Inhibition of PKC (unknown origin) using acetylated myelin basic protein (4 to 14 residues) as substrate incubated for [gamma-32P]-ATP incubated for 5 mins by scintillation counter analysis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on